14.01
-0.24(-1.68%)
Currency In USD
| Previous Close | 14.25 |
| Open | 14.25 |
| Day High | 14.34 |
| Day Low | 13.51 |
| 52-Week High | 21.48 |
| 52-Week Low | 3.22 |
| Volume | 592,471 |
| Average Volume | 418,003 |
| Market Cap | 375.71M |
| PE | -77.83 |
| EPS | -0.18 |
| Moving Average 50 Days | 16.55 |
| Moving Average 200 Days | 13.07 |
| Change | -0.24 |
If you invested $1000 in Eton Pharmaceuticals, Inc. (ETON) since IPO date, it would be worth $2,241.6 as of July 01, 2025 at a share price of $14.01. Whereas If you bought $1000 worth of Eton Pharmaceuticals, Inc. (ETON) shares 5 years ago, it would be worth $2,445.03 as of July 01, 2025 at a share price of $14.01.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
GlobeNewswire Inc.
Jun 27, 2025 10:50 AM GMT
DEER PARK, Ill., June 27, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
GlobeNewswire Inc.
May 28, 2025 9:28 PM GMT
• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution• Commercial launch expected the week of June 2nd• Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral granules to exceed $50 million DEER
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences
GlobeNewswire Inc.
May 14, 2025 8:30 PM GMT
DEER PARK, Ill., May 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that